The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...
What Is A Biventricular Pacemaker Or A CRT Device, How Is It Implanted, And Who Is A Good Candidate?
Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
Indianapolis, IN - A European postmarketing surveillance study of Guidant Corporation's cardiac resynchronization device for use in heart failure (HF) has shown that 60% of the 1000 patients using it ...
The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...
Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...
Please provide your email address to receive an email when new articles are posted on . A universal remote monitoring platform was associated with lower mortality and fewer hospitalizations than ...
COLLEGE PARK, Md. - Federal health advisers said Thursday that an electronic heart implant should be approved for a large group of patients who currently aren't eligible. A Food and Drug ...
Relevant risk for interaction seen with cardiac implantable electronic devices; no signs of cardiac damage seen during testing. HealthDay News — When applied to cardiac implantable electronic devices ...
Medtronic is recalling nearly 350,000 implantable cardiac devices due to continued problems with the delivery of high-voltage energy, according to an announcement from the US Food and Drug ...
AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback